REFERENCES
- Souza E, Burillo A, Munoz. P. Catheter-related infec-tions: diagnosis and intravascular treatment. Clin Microbiol Infect 2002; 8 (5): 265–74.
- Donlan RM, Costerton JW. Biofilms: survival mecha-nisms of clinically relevant microrganisms. Clin Microbiol Rev 2002; 15: 167–193.
- Donetz AP, Harvey RA, Greco RS. Stability of antibi-otics to polytetrafluoroethylene with cationic surfactants. J Clin Microb 1984; 19 (1): 1–3.
- Maki DG, Stolz SM, Wheeler SJ, Mermel LA. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. Ann Intern Med 1997; 127 (4): 257–266.
- Sherertz RJ, Carruth WA, Hampton AA, Byron MP, Solomon DD. Efficacy of antibiotic-coated catheters in pre-venting subcutaneous Staphylococcus aureus infection in rab-bit. J Infect Dis 1993; 167: 98–106.
- O'Grady NP, Alexander M., Dellinger EP et al. Guidelines for the prevention of intravascular catheter-related infections. Center for Disease Control and Prevention. MMWR 2002; 9 (51): 1–29.
- Mah TF, O'Toole GA. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 2001; 9: 34–39.
- Donelli G, De Paoli P, Fadda G, Marone P, Nicoletti G, Varaldo PE. A multicenter study on central venous catheter-associated infections in Italy. J Chemother 2001; 13 Spec No 1: 251-262.
- Donelli G, Francolini I. Efficacy of antiadhesive, antibiotic and antiseptic coatings in preventig catheter-related infec-tions: review. J Chemother 2001; 13 (6): 56–67.
- Marconi W, Galoppa A, Martinelli A, Piozzi A. New polyurethane compositions able to bond high amounts of both albumin and heparin. II: Copolymers and polymer blends. Biomaterials 1996; 17 (18): 1795–802.
- Schierholz JM, Beuth J. Implant infections: a haven for opportunistic bacteria. J Hosp Infect 2001; 49 (2): 87–93.
- Stewart PS, Costerton JW. Antibiotic resistance of bac-teria in biofilms. Lancet 2001; 358: 135–138.
- Darouiche RO, Raad II, Heard SO et al. A comparison of two antimicrobial-impregnated central venous catheters. N Engl J Med 1999; 340: 1–8.
- Raad I, Darouiche R, Hachem R, Mansouri M, Bodey GP. The broad-spectrum activity and efficacy of catheters coated with minocycline and rifampin. J Infect Dis 1996; 173: 418–24.
- O'Grady NP, Gerberding JL, Weinstein RA, Masur H. Patient safety and the science of prevention: the time for implementing the Guidelines for the prevention of intravascu-lar catheter-related infections is now. Crit Care Med 2003; 31 (1): 291–2.
- Danese PN. Antibiofilm approaches: prevention of catheter colonization. Chem Biol 2002; 9: 873–880.
- Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 1999; 284: 1318–22.
- Elliott TS. The prevention of central venous catheter-related sepsis. J Chemother 2001; 13: Spec No 1: 234-8.
- Safdar N, Kluger DM, Maki DG. A review of risk fac-tors for catheter-related bloodstream infection caused by per-cutaneously inserted, noncuffed central venous catheters: implications for preventive strategies. Medicine (Baltimore) 2002; 81 (6): 466–79.
- Marconi W, Francolini I, Piozzi A, Di Rosa R. Antibiotic releasing urethane polymers for prevention of catheter related infections. Bioact Compat Polym 2001; 16 (5): 393–407.
- Yorganci K, Krepel C, Weigelt JA, Edmiston CE. Activity of antibacterial impregnated central venous catheter against Klebsiella pneumoniae. Intensive Care Med 2002; 28: 438–442.
- National Committee for clinical laboratory standards. Methods for dilution antimicrobial susceptability tests for bacte-ria that grow aerobically. M7-A2. National Committee for clin-ical laboratory standards, Villanova, Pa, 1990.
- Mermel LA. New technologies to prevent intravascular catheter-related bloodstream infections. Emerg Infect Dis 2001; 7 (2): 197–9.
- Donelli G, Francolini I, Piozzi A, Di Rosa R, Marconi W. New polymer-antibiotic systems to inhibit bacterial biofilm formation: a suitable approach to prevent central venous catheter-associated infections. J Chemother 2002; 14 (5): 501–507.